BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25538615)

  • 1. Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae.
    Little CS; Joyce TA; Hammond CJ; Matta H; Cahn D; Appelt DM; Balin BJ
    Front Aging Neurosci; 2014; 6():304. PubMed ID: 25538615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection.
    Boelen E; Stassen FR; van der Ven AJ; Lemmens MA; Steinbusch HP; Bruggeman CA; Schmitz C; Steinbusch HW
    Acta Neuropathol; 2007 Sep; 114(3):255-61. PubMed ID: 17581756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice.
    Little CS; Hammond CJ; MacIntyre A; Balin BJ; Appelt DM
    Neurobiol Aging; 2004 Apr; 25(4):419-29. PubMed ID: 15013562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain.
    Hammond CJ; Hallock LR; Howanski RJ; Appelt DM; Little CS; Balin BJ
    BMC Neurosci; 2010 Sep; 11():121. PubMed ID: 20863379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease.
    Lim C; Hammond CJ; Hingley ST; Balin BJ
    J Neuroinflammation; 2014 Dec; 11():217. PubMed ID: 25540075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer's disease risk.
    Chacko A; Delbaz A; Walkden H; Basu S; Armitage CW; Eindorf T; Trim LK; Miller E; West NP; St John JA; Beagley KW; Ekberg JAK
    Sci Rep; 2022 Feb; 12(1):2759. PubMed ID: 35177758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating
    Lehrer S; Rheinstein PH
    In Vivo; 2022; 36(6):2650-2653. PubMed ID: 36309404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice.
    Little CS; Bowe A; Lin R; Litsky J; Fogel RM; Balin BJ; Fresa-Dillon KL
    Infect Immun; 2005 Mar; 73(3):1723-34. PubMed ID: 15731073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P.
    Ezzahiri R; Stassen FR; Kurvers HR; Dolmans V; Kitslaar PJ; Bruggeman CA
    APMIS; 2006 Feb; 114(2):117-26. PubMed ID: 16519748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae.
    Pinchuk I; Starcher BC; Livingston B; Tvninnereim A; Wu S; Appella E; Sidney J; Sette A; Wizel B
    J Immunol; 2005 May; 174(9):5729-39. PubMed ID: 15843575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease.
    Al-Atrache Z; Lopez DB; Hingley ST; Appelt DM
    BMC Neurosci; 2019 Feb; 20(1):6. PubMed ID: 30786875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Genetic Transformation of Chlamydia pneumoniae.
    Shima K; Wanker M; Skilton RJ; Cutcliffe LT; Schnee C; Kohl TA; Niemann S; Geijo J; Klinger M; Timms P; Rattei T; Sachse K; Clarke IN; Rupp J
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30305318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?
    Shima K; Kuhlenbäumer G; Rupp J
    Med Microbiol Immunol; 2010 Nov; 199(4):283-9. PubMed ID: 20445987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae infection of brain cells: an in vitro study.
    Boelen E; Steinbusch HW; van der Ven AJ; Grauls G; Bruggeman CA; Stassen FR
    Neurobiol Aging; 2007 Apr; 28(4):524-32. PubMed ID: 16621171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
    Hahn DL
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):271-88, 291; quiz 291-2. PubMed ID: 10541419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Infection of Chlamydia Pneumoniae.
    Ma Y; Sun J; Che G; Cheng H
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Signs of active infection with Chlamydia pneumoniae in patients with coronary heart disease].
    Hrubá D; Roubalová K; Kraml P; Andĕl M
    Cas Lek Cesk; 2004; 143(12):830-5. PubMed ID: 15730214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb.
    Rusznák Z; Kim WS; Hsiao JH; Halliday GM; Paxinos G; Fu Y
    J Alzheimers Dis; 2016; 49(2):443-57. PubMed ID: 26484907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent.
    Tvinnereim A; Wizel B
    J Immunol; 2007 Sep; 179(6):3947-57. PubMed ID: 17785832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Antibiotic Treatment of
    Ou H; Chien WC; Chung CH; Chang HA; Kao YC; Wu PC; Tzeng NS
    Front Aging Neurosci; 2021; 13():701899. PubMed ID: 34489674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.